Literature DB >> 22972384

From Tyrian purple to kinase modulators: naturally halogenated indirubins and synthetic analogues.

Konstantina Vougogiannopoulou1, Alexios-Leandros Skaltsounis.   

Abstract

Indirubins represent a small category of compounds with significant pharmacological activity focusing on the inhibition of protein kinases. A series of derivatives has been developed during the last 15 years aiming the investigation and amelioration of the indirubin scaffold in terms of activity, selectivity, and drug-likeness. The current article focuses on the naturally brominated indirubins present in the famous historic dye of Tyrian purple, attempting to gather all available literature regarding biosynthesis, isolation, and synthesis of related analogues. Halogenated indirubins are by far one of the most important subcategories of indirubins, with its main representatives 6-bromoindirubin (6BI) and 6-bromoindirubin-3'-oxime (6BIO) possessing an increased selectivity against GSK-3. This review attempts to summarize concisely structure/activity relationships among closely related halogenated analogues in terms of protein kinase inhibition and selectivity, while it also focuses on the various biological applications arising from the interactions of halogenated indirubins with molecular targets. Those include effects of halogenated indirubins on stem cells, cardiac, renal, and pancreatic cells, on leukemia and solid tumors, and on neurodegeneration. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22972384     DOI: 10.1055/s-0032-1315261

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  17 in total

1.  6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells.

Authors:  Xiaowei Zhang; Daniela Castanotto; Sangkil Nam; David Horne; Cy Stein
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

2.  Pharmacological intervention in young adolescents rescues synaptic physiology and behavioural deficits in Syngap1+/- mice.

Authors:  Vijaya Verma; M J Vijay Kumar; Kavita Sharma; Sridhar Rajaram; Ravi Muddashetty; Ravi Manjithaya; Thomas Behnisch; James P Clement
Journal:  Exp Brain Res       Date:  2021-11-05       Impact factor: 1.972

Review 3.  Recent progress in neuroactive marine natural products.

Authors:  Ryuichi Sakai; Geoffrey T Swanson
Journal:  Nat Prod Rep       Date:  2014-01-17       Impact factor: 13.423

4.  Natural-Based Indirubins Display Potent Cytotoxicity toward Wild-Type and T315I-Resistant Leukemia Cell Lines.

Authors:  Nicolas Gaboriaud-Kolar; Vasillios Myrianthopoulos; Konstantina Vougogiannopoulou; Panagiotis Gerolymatos; David A Horne; Richard Jove; Emmanuel Mikros; Sangkil Nam; Alexios-Leandros Skaltsounis
Journal:  J Nat Prod       Date:  2016-10-11       Impact factor: 4.803

Review 5.  Are the Traditional Medical Uses of Muricidae Molluscs Substantiated by Their Pharmacological Properties and Bioactive Compounds?

Authors:  Kirsten Benkendorff; David Rudd; Bijayalakshmi Devi Nongmaithem; Lei Liu; Fiona Young; Vicki Edwards; Cathy Avila; Catherine A Abbott
Journal:  Mar Drugs       Date:  2015-08-18       Impact factor: 5.118

6.  Combined Effects of Muricid Extract and 5-Fluorouracil on Intestinal Toxicity in Rats.

Authors:  Roger Yazbeck; Ruth Lindsay; Catherine A Abbott; Kirsten Benkendorff; Gordon S Howarth
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-13       Impact factor: 2.629

7.  6-bromo-indirubin-3'-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts.

Authors:  Aimilia D Sklirou; Nicolas Gaboriaud-Kolar; Issidora Papassideri; Alexios-Leandros Skaltsounis; Ioannis P Trougakos
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

Review 8.  Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential.

Authors:  Igor A Schepetkin; Mark B Plotnikov; Andrei I Khlebnikov; Tatiana M Plotnikova; Mark T Quinn
Journal:  Biomolecules       Date:  2021-05-22

Review 9.  Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases.

Authors:  Tina Blažević; Elke H Heiss; Atanas G Atanasov; Johannes M Breuss; Verena M Dirsch; Pavel Uhrin
Journal:  Evid Based Complement Alternat Med       Date:  2015-09-17       Impact factor: 2.629

10.  An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein kinase 3.

Authors:  Antonia Efstathiou; Nicolas Gaboriaud-Kolar; Despina Smirlis; Vassilios Myrianthopoulos; Konstantina Vougogiannopoulou; Alexandros Alexandratos; Marina Kritsanida; Emmanuel Mikros; Ketty Soteriadou; Alexios-Leandros Skaltsounis
Journal:  Parasit Vectors       Date:  2014-05-20       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.